Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release.
1980523 citationsLaurence A. Harker, Thomas W. Malpass et al.Bloodprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Herman Branson
Since
Specialization
Citations
This map shows the geographic impact of Herman Branson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Branson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Branson more than expected).
This network shows the impact of papers produced by Herman Branson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Branson. The network helps show where Herman Branson may publish in the future.
Co-authorship network of co-authors of Herman Branson
This figure shows the co-authorship network connecting the top 25 collaborators of Herman Branson.
A scholar is included among the top collaborators of Herman Branson based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Herman Branson. Herman Branson is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Elias, Alan N., et al.. (1985). Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis.. PubMed. 77(7). 561–5.2 indexed citations
3.
Branson, Herman, et al.. (1984). Heritable alpha 2-macroglobulin deficiency in a patient with arterial thrombosis: alpha 2-macroglobulin deficiency Irvine.. PubMed. 76(11). 1107–12.3 indexed citations
Harker, Laurence A., Thomas W. Malpass, Herman Branson, Eugene A. Hessel, & Sherrill J. Slichter. (1980). Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release.. Blood. 56(5). 824–34.523 indexed citations breakdown →
Branson, Herman, et al.. (1958). Studies of sickle cell anemia. III. Plasma proteins in normal and sickle cell anemia blood.. PubMed. 50(1). 27–30.3 indexed citations
16.
Peck, Franklin B & Herman Branson. (1958). Studies of sickle cell anemia. II. Phosphatase activities in normal and sickle cell anemic blood.. PubMed. 50(1). 25–6.
17.
Branson, Herman. (1958). Some Membrane Phenomena From The Point Of View Of Information Theory. 197.1 indexed citations
Branson, Herman. (1952). The Negro And Scientific Research. 15(7). 131.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.